Dive Brief: French pharmaceutical company Sanofi is proceeding with plans to sell U.S.-based private...
Dive Brief: Lexicon Pharmaceuticals is selling rights to its only marketed drug outside of...
Dive Brief: Sanofi will invest 300 million euros, or about $325 million, for a...
Dive Brief: CVS Health on Thursday replaced CEO Karen Lynch as the healthcare and pharmacy...
Today, a brief rundown of news from PTC Therapeutics and Novartis, as well as...
Dive Brief: Gilead will no longer sell its combination drug Trodelvy to treat bladder...
Dive Brief: An experimental antibody drug developed by Merck & Co. significantly reduced the...
People with advanced Parkinson’s disease have a new treatment option, as the Food and...
Sage Therapeutics is restructuring yet again, announcing Thursday a company shakeup that will involve...
Clinical trial results released by Wave Life Sciences Wednesday appear to provide early validation...
Dive Brief: The Food and Drug Administration on Tuesday approved a new device to...
Dive Brief: Sales of Johnson & Johnson’s cancer therapy Carvykti and immune disease drug...
Dive Brief: European life sciences venture firm Forbion on Tuesday said it has raised...
Danish drugmaker Lundbeck has agreed to spend $2.6 billion acquiring a young biotechnology company...
The Food and Drug Administration has temporarily deflected a lawsuit alleging it violated federal...
Within the pharmaceutical industry, a multibillion-dollar race is underway to top Novo Nordisk’s and...
The number of medical devices with artificial intelligence technology has risen sharply in the...
Dive Brief: UnitedHealth Group and CVS Health want Federal Trade Commission Chair Lina Khan...
Dive Brief: Upstream Bio announced Thursday it priced its initial public offering, raising $255...
Today, a brief rundown of news from Roche and Turnstone Biologics, as well as...
For the past year, French pharmaceutical giant Sanofi has been searching for a buyer...
Two former Pfizer executives announced late Wednesday night that they won’t support efforts by...
Biotechnology company Purespring Therapeutics has raised about $105 million to fund its development of...
Dive Brief: Eli Lilly and Insitro said they have entered into three drug development...
Alzheimer’s disease remains one of the world’s most indomitable illnesses, and on Tuesday it...
Since stepping down as CEO of Alnylam Pharmaceuticals three years ago, John Maraganore has...
Dive Brief: GSK-backed ViiV Healthcare on Monday said it plans to triple the amount...
Dive Brief: An experimental, muscle-preserving therapy from Scholar Rock succeeded in a Phase 3...
Dive Brief: Eli Lilly on Wednesday announced plans to spend $4.5 billion on a...
Cassava Sciences has faced intense regulatory scrutiny over alleged clinical impropriety in studies of...
Today, a brief rundown of news from Bristol Myers Squibb and Johnson & Johnson,...
Over the past decade, the medicine Enjaymo has been passed around no less than...
Dive Brief: Gene editing company Editas Medicines has sold off license fees and future...
Dive Brief: A major California health plan has struck a novel deal with a...
The U.S. government is fine-tuning the rules for how it will negotiate drug prices...
Dive Brief: Shortages affecting the availability of Eli Lilly’s top-selling diabetes and weight-loss drugs...
Dive Brief: Gilead on Wednesday said it signed royalty-free licensing agreements with six generic...
Dive Brief: Triveni Bio has raised $115 million in Series B funding, the company...
With rare exceptions, biotechnology and pharmaceutical companies validate their business plans through clinical trials,...
Boston-based Aktis Oncology has raised $175 million in fresh funding to advance its pipeline...
Dive Brief: Roche on Monday agreed to pay $850 million to acquire two experimental...
Precision oncology continues to be one of the fastest-growing markets within pharmaceuticals. Valued at...
2Seventy bio, the cancer-focused drugmaker spun out of Bluebird bio, has decided to stop...
Genespire, an Italy-based biotechnology startup making “off-the-shelf” gene therapies treatment for rare pediatric genetic...
Dive Brief: Pfizer is pulling the sickle cell disease drug Oxbryta off the market...
Dive Brief: Two House Democrats have called for an investigation of former Food and...
Today, a brief rundown of news from J&J and the FDA, as well as...
The Food and Drug Administration on Friday approved Regeneron Pharmaceuticals and Sanofi’s inflammatory disease...
For the first time in more than two decades, a completely new form of...
Arch Venture Partners, a prominent creator of biotechnology startups, has raised more than $3...
BioAge Labs has raised $198 million in an initial public offering, the company announced...
Novo Nordisk’s top executive vowed to reopen price negotiations with insurers covering the company’s...
After more than two decades of work, partners Biogen and UCB say they finally...
Dive Brief: An experimental medicine from AstraZeneca and Daiichi Sankyo failed to help people...
Glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) are entero-pancreatic hormone-based treatments first approved in...
A new company born out of research done by top Harvard genetic scientist George...
Dive Brief: 23andMe’s independent board directors resigned on Tuesday amid uncertainty about the DNA...
European drug regulators have officially turned back a first-of-its-kind eye drug from Apellis Pharmaceuticals...
Today, a brief rundown of news from Sanofi and Novo Nordisk, as well as...
Dive Brief: The Federal Trade Commission has filed suit against the three largest pharmacy...
Dive Brief: Roche’s antiviral drug Xofluza reduced influenza transmission among household contacts in a...
Dive Brief: People with a common form of macular degeneration needed far fewer injections...
Dive Brief: Organon has agreed to buy Roivant’s dermatology subsidiary Dermavant for $175 million...
Today, a brief rundown of news from Novartis and GSK, as well as updates...
BioMarin Pharmaceutical, after months of layoffs, spending cuts and research reorganizations, has staked its...
Dive Brief: An antibody-drug conjugate developed by Daiichi Sankyo and Merck & Co. met...
Sanofi said it’s ready to meet demand for its RSV shot Beyfortus this year,...
Over the weekend at the European Society for Medical Oncology’s annual meeting in Barcelona,...
For novel therapeutics, the path to marketing authorization is narrow and treacherous. Among promising...
A decade of follow-up on people with melanoma who were treated with cancer immunotherapy...
Vironexis Biotherapeutics emerged from stealth with plans to start what it claims will be...
Small biotechnology company iTeos Therapeutics could succeed where larger drugmakers have fallen short, should...
Today, a brief rundown of news from Roche and Gilead Sciences, as well as...
Months after winning approval of a new vaccine for respiratory syncytial virus, Moderna is...
Three drug startups collectively raised more than $700 million in initial public offerings Thursday,...
Dive Brief: An experimental drug Fulcrum Therapeutics has been testing against a type of...
U.K.-based biotechnology company F2G has raised $100 million to complete late-stage testing of a...
Dive Brief: BridgeBio Pharma plans to trim its spending on gene therapy research by...
Early results from a small study have convinced Centessa Pharmaceuticals to “rapidly advance” an...
Bain Capital Life Sciences said Tuesday it has secured about $3 billion for its...
Dive Brief: An experimental weight loss pill developed by biotechnology company Terns Pharmaceuticals helped...
Dive Brief: An experimental drug regimen for breast cancer being developed by Relay Therapeutics...
The relentless impact of Alzheimer’s disease (AD) on individuals, families, and societies worldwide is...
An experimental medicine from a small biotechnology company cut the risk of lung cancer...
Dive Brief: Novartis said Wednesday it’s expanding a manufacturing site in Indianapolis and building...
Dive Brief: GSK on Friday said its Nucala medicine succeeded in a Phase 3...
Today, a brief rundown of news from OrsoBio, as well as updates from Boehringer...
Dive Brief: A Delaware judge ruled Wednesday that Johnson & Johnson must pay Auris...
Eli Lilly on Thursday revealed new data that could help it catch rival Novo...
The CEO of Lykos Therapeutics will step down after the company’s efforts to win...
Today, a brief rundown of news from Biogen, as well as updates from Dyne...
BioMarin Pharmaceutical has brought eight rare disease drugs to market over the past 25...
Dive Brief: Shares in vaccine developer Vaxcyte soared by over 35% Tuesday after the...
Regulators in the U.S. and Europe recently determined that a popular group of drugs...
In today’s fast-paced healthcare landscape, digital intelligence has become a critical asset for pharmaceutical...
The psychedelic drug field hit a setback this month when the Food and Drug...
The chair of the powerful House Committee on Oversight and Accountability is threatening the...
Investment in developers of cell and gene therapies has nosedived this year, a sharp...
Johnson & Johnson is asking the Food and Drug Administration to approve a new...
Two months ago, Alnylam Pharmaceuticals revealed that a medicine it’s been developing for people...
Today, a brief rundown of news from Novo Nordisk and Ventyx Biosciences, as well...
Dive Brief: Merck & Co.’s drug Keytruda failed to help people with cancer in...
Amid a major corporate shakeout, BioMarin Pharmaceutical intends to lay off over 200 staff,...
Bayer and biotechnology company NextRNA Therapeutics on Wednesday said they have partnered to develop...
Neurocrine Biosciences on Wednesday reported results from a schizophrenia drug study that, despite one...
Dive Brief: Eli Lilly is now distributing a single-dose vial form of its popular...
Pfizer on Tuesday launched a direct-to-consumer service it claims will help people schedule telehealth...
Genetic medicines startup Tome Biosciences is letting go of much of its staff after...
Dive Brief: The European Commission has authorized Regeneron’s dual-acting drug odronextamab to treat two...
Listen to the article 4 min This audio is auto-generated. Please let us know...
Chinook Therapeutics ranks among Versant Ventures’ most successful biotechnology bets. The kidney disease drug...
Leqembi’s benefits are “too small to justify the significant cost to the NHS,” said...
The Food and Drug Administration is defending the record of Jeff Shuren, former director...
Dive Brief: A pair of U.S. biotechnology companies on Thursday filed plans for initial...
Dive Brief: The Food and Drug Administration on Thursday cleared new versions of Pfizer’s...
BridgeBio Pharma has transferred several preclinical and early clinical-stage drugs to a new company,...
Dive Brief: After warning investors earlier this month of a possible delay, Regeneron Pharmaceuticals...
Today, a brief rundown of stock sales by Avidity Biosciences and Kymera Therapeutics, as...
Dive Brief: The Food and Drug Administration has approved a new combination drug regimen...
A subsidiary of Danish drugmaker Novo Nordisk is investing 1.5 billion Danish kroner, or...
BioNTech partner MediLink Therapeutics can resume enrollment of a Phase 1 clinical trial testing...
The U.S. government on Thursday said it stands to save taxpayers $6 billion on...
Dive Brief: Gilead Sciences has won Food and Drug Administration approval to sell Livdelzi,...
The Biden administration struck a triumphant tone on Thursday in rolling out the first...
Today, a brief rundown of news from Zealand Pharma and Bluebird Bio, as well...
Dive Brief: Pfizer and BioNTech on Friday said a combination flu and COVID-19 shot...
Lykos Therapeutics plans to lay off about 75% of its staff as part of...
The Food and Drug Administration has approved another medicine for a rare condition that...
Dive Brief: Evotec, a German drug discovery and contract development and manufacturing company, is...
Dive Brief: Grail said it will lay off about 350 employees in a restructuring...
Dive Brief: Acelyrin, the biotechnology company behind the sector’s largest initial public offering last...
Dive Brief: Galderma on Tuesday said the Food and Drug Administration has approved its...
Dive Brief: Pfizer on Monday said its RSV vaccine Abrysvo led to strong immune...
A day after the Food and Drug Administration rejected MDMA as a therapy aid...
Dive Brief: Eli Lilly on Tuesday raised its revenue forecast for the year by...
Dive Brief: Recursion and Exscientia, two artificial intelligence firms, on Thursday announced that they...
Eli Lilly is making progress resolving the supply strains that for months have made...
The recent downturn in the biotechnology sector affected startups in many ways, from the...
The Food and Drug Administration has rejected a bid to get MDMA approved as...
Merck & Co. on Friday acquired an experimental drug designed to wipe out the...
Today, a brief rundown of news from Merck & Co. and Cabaletta Bio, as...
Dive Brief: Treatment with an Apellis Pharmaceuticals drug appeared to benefit people with one...
Dive Brief: Novo Nordisk shares tumbled 7% in early trading Wednesday after the company...
Today, a brief rundown of news from Amgen and Servier, as well as updates...
Dive Brief: Arie Belldegrun, the founder of Allogene Therapeutics and Kite Pharma, unveiled a...
Despite decades of research and many millions of dollars invested, Roche still has yet...
Bristol Myers Squibb has returned an experimental cancer immunotherapy to Agenus, ending an alliance...
Dive Brief: All doses of tirzepatide, the drug Eli Lilly sells as Zepbound for...
Dive Brief: Cigna’s chief executive is pledging to be more aggressive in defending its...
Shares of Moderna fell nearly 20% on Thursday after the company lowered its 2024...
Eli Lilly’s tirzepatide, the in-demand drug sold as Zepbound for weight loss, has for...
Prominent gene therapy researcher Jim Wilson will depart the University of Pennsylvania, where he...
Today, a brief rundown of news from Vir Biotechnology and Vertex Pharmaceuticals, as well...
The Food and Drug Administration on Thursday approved a new type of cellular medicine,...
Dive Brief: Gene therapy developer UniQure will shrink its workforce by 65%, cutting 300...
After a slow start, the launch of Biogen’s prized drug for Alzheimer’s disease is...
Dive Brief: GSK on Wednesday lowered its forecast for vaccine sales this year, citing...
Today, a brief rundown of news from Vertex Pharmaceuticals and Merck & Co. as...
Pfizer missed its first chance at following Novo Nordisk and Eli Lilly into the...
Dive Brief: Incyte is cutting down its pipeline of experimental cancer drugs, announcing Tuesday...
After a dramatic post-pandemic downturn, a sense of stabilization has returned to biotech, and...
Dive Brief: An experimental heart drug from biotechnology company NewAmsterdam Pharma met its main...
Viking Therapeutics shares soared by more than 30% early Thursday after the company told...
Dive Brief: Sen. Elizabeth Warren, D-Mass., introduced legislation that would reverse the Supreme Court’s...
A key regulatory committee that influences whether new drugs enter the European market has...
Today, a brief rundown of news from AbbVie and AstraZeneca as well as updates...
Bristol Myers Squibb on Friday raised its forecast for revenue and profit per share...
Shares of French pharmaceutical giant Sanofi ticked up Thursday morning with the release of...
Roche is best known for the cancer drugs that still account for much of...
Dive Brief: An experimental gene therapy from Pfizer succeeded in a Phase 3 study...
In 2020, Biogen wagered more than $1 billion on two experimental drugs developed in...
Dive Brief: A two-year-old biotechnology startup led by former Johnson & Johnson executives has...
Dive Brief: An experimental Merck & Co. drug designed to protect infants from illness...
Ionis Pharmaceuticals plans to push one of its rare disease drugs into late-stage testing...
The U.S. government will not give Bluebird bio a green light to offer fertility...
Recent advancements in immune checkpoint inhibitors (ICIs) targeting PD-1 or CTLA4 have shown significant...
Dive Brief: Gilead chief medical officer Merdad Parsey will step down from his role...
Today, a brief rundown of news from Caribou Sciences and Relay Therapeutics as well...
Dive Brief: A closely watched obesity pill being developed by Roche helped people in...
Today, a brief rundown of news from Morphic Holding as well as updates from...
Cybersecurity firm CrowdStrike triggered a massive IT outage on Friday, disrupting businesses, including healthcare, after issuing...
Boehringer Ingelheim will sell an unbranded version of its Humira biosimilar at a 92%...
Dive Brief: Artiva Biotherapeutics on Thursday raised $167 million in an initial public offering centered...
Dive Brief: Sales of Johnson & Johnson’s depression drug Spravato accelerated in the second...
Medical device companies have been steadily cutting jobs for the past 18 months, eliminating...
Dive Brief: NGM Biopharmaceuticals, which was taken private earlier this year, has raised $122...
Dive Brief: Biotechnology startup Cardurion Pharmaceuticals on Tuesday raised a $260 million Series B...
Asceneuron, a Switzerland-based biotechnology company, has raised another $100 million to support its work...
Dive Brief: An experimental cancer drug developed by Revolution Medicines shrank pancreatic tumors in...
The popularity of new GLP-1 drugs for weight loss is giving rise to a...
Dive Brief: Flagship Pioneering said Wednesday that it’s added another $3.6 billion to its...
The recent U.S. Supreme Court decision to overturn the Chevron doctrine could open the...
Pharmaceutical companies face a looming patent cliff over the next several years, as generic...
Today, a brief rundown of news from Eisai, Spark Therapeutics and Ipsen as well...
Dive Brief: The Food and Drug Administration rejected Novo Nordisk’s application to sell a...
With tens of billions of dollars at stake, some of the world’s largest drug...
Today, a brief rundown of news from AbbVie and Skyhawk Therapeutics, as well as...
Dive Brief: The Federal Trade Commission is preparing to sue the three largest pharmacy...
